New Paper: From Birth to Overweight and Atopic Disease: Multiple and Common Pathways of the Infant Gut Microbiome
Congratulations to our Platform 2 Lead Dr. Anita Kozyrskyj on this recent publication! This recent study from Dr. Kozyrskyj’s team and colleagues highlights how birth factors from the CHILD study cohort (@CHILDSTUDY) correlate to changes in the gut microbes of infants to “determine the pathways by which these alterations may lead to an increased risk […]
New Paper: Decreasing Antibiotic Use, The Gut Microbiota, and Asthma Incidence in Children: Evidence From Population-Based and Prospective Cohort Studies
The authors investigated if the decreases in asthma incidence are linked to reduced antibiotic prescribing and mediated by changes in the gut microbiota.
Platform 2 | Human Cohort Design & Analysis
Platform 2 Human Cohort Design & Analysis Our Platform 2 Experts Dr Anita Kozyrskyj Dr. Marie-Claire Arrieta “We aim to support the integration of microbiome collection and analysis in human cohort studies to advance clinical and translational research towards a better understanding of microbiome function in human health and disease.” Additional support for Platform 2 […]
